Pulse Infoframe Inc. reposted this
Among the exceptional One Nucleus #GenesisLondon2024 Fringe Events is "Discovery to Commercialisation in Rare Diseases - The Role of Real-World Evidence (RWE)" hosted by J A Kemp. This discussion will delve into how RWE can enhance drug discovery, clinical trial innovation, and commercialisation with a focus on rare diseases as a model, offering insights applicable across the therapeutic landscape. Join an outstanding line-up of experts Tony Jones (One Nucleus), Ron (Roni) A. Jortner (Aspire Biosciences), Femida Gwadry-Sridhar (Pulse Infoframe Inc.), Ravi Srinivasan (J A Kemp) and Julie Adrian (FINN Partners) as they explore how effectively leveraging RWE can bring groundbreaking treatments to patients. Seats are limited—learn more and secure your spot here: https://lnkd.in/ePNaXY4c
Founder, Aspire Biosciences
1moThank you Tony Jones for the opportunity to discuss the role of Real World Evidence and for choosing rare disease as the model system. By its inherent nature, in the rare disease field both the challenges and the benefits get amplified - like looking at it all under a very powerful lense. And particularly in R&D - even well before any clinical development - patients play a crucial part in building the evidence base. At Aspire Biosciences we have turned patient-provided data into a power tool for boosting discovery and development, and our work procedures are all optimised around collating, vetting and leveraging it. I look forward to discussing this in the broad context of the panel and to the learnings of Femida Gwadry-Sridhar, Ravi Srinivasan and Julie Adrian.